January 28th, 2011 - Volume 25 - Issue 3 - Contributor Index

Alphabetical Search
I
Q
U
X

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Author:
Anema, Aranka
Author:
Arribas, Jose

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors

Salgado, Maria; Kirk, Gregory D; Cox, Andrea; More

AIDS. 25(3):385-387, January 28th, 2011.

Author:
Bae, Jason W
Author:
Bajos, Nathalie

A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population

Nelson, Mark; Stellbrink, Hans-Jürgen; Podzamczer, Daniel; More

AIDS. 25(3):335-340, January 28th, 2011.

Author:
Bickel, Markus

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Soliman, Elsayed Z; Lundgren, Jens D; Roediger, Mollie P; More

AIDS. 25(3):367-377, January 28th, 2011.

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors

Salgado, Maria; Kirk, Gregory D; Cox, Andrea; More

AIDS. 25(3):385-387, January 28th, 2011.

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy

Goodman, Derrick D; Zhou, Yun; Margot, Nicolas A; More

AIDS. 25(3):325-333, January 28th, 2011.

Author:
Bosch, Ronald J
Author:
Bower, Mark
Author:
Bream, Jay H

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Author:
Burger, David

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Author:
Calvez, Vincent

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Author:
Chun, Tae-Wook

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Author:
Collier, Ann C
Author:
Cox, Andrea

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors

Salgado, Maria; Kirk, Gregory D; Cox, Andrea; More

AIDS. 25(3):385-387, January 28th, 2011.

Author:
Detels, Roger
Author:
Dewar, Robin

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Soliman, Elsayed Z; Lundgren, Jens D; Roediger, Mollie P; More

AIDS. 25(3):367-377, January 28th, 2011.

Author:
Ellis, Ronald
Author:
Evans, Scott

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Soliman, Elsayed Z; Lundgren, Jens D; Roediger, Mollie P; More

AIDS. 25(3):367-377, January 28th, 2011.

Author:
Fourati, Slim

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Author:
Gazzard, Brian

A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population

Nelson, Mark; Stellbrink, Hans-Jürgen; Podzamczer, Daniel; More

AIDS. 25(3):335-340, January 28th, 2011.

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy

Goodman, Derrick D; Zhou, Yun; Margot, Nicolas A; More

AIDS. 25(3):325-333, January 28th, 2011.

Author:
Grimm, Kristy
Author:
Gu, Wenjuan

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Author:
Guyer, William

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Author:
Higgins, Yvonne

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors

Salgado, Maria; Kirk, Gregory D; Cox, Andrea; More

AIDS. 25(3):385-387, January 28th, 2011.

Author:
Hill, Andrew

A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population

Nelson, Mark; Stellbrink, Hans-Jürgen; Podzamczer, Daniel; More

AIDS. 25(3):335-340, January 28th, 2011.

Author:
Ho, Jason

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Author:
Kirk, Gregory D

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors

Salgado, Maria; Kirk, Gregory D; Cox, Andrea; More

AIDS. 25(3):385-387, January 28th, 2011.

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Author:
Kovacs, Colin

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Author:
Kwara, Awewura
Author:
Lavignon, Marc

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Author:
Letendre, Scott

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Soliman, Elsayed Z; Lundgren, Jens D; Roediger, Mollie P; More

AIDS. 25(3):367-377, January 28th, 2011.

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy

Goodman, Derrick D; Zhou, Yun; Margot, Nicolas A; More

AIDS. 25(3):325-333, January 28th, 2011.

Author:
Marks, Stephan

A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population

Nelson, Mark; Stellbrink, Hans-Jürgen; Podzamczer, Daniel; More

AIDS. 25(3):335-340, January 28th, 2011.

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy

Goodman, Derrick D; Zhou, Yun; Margot, Nicolas A; More

AIDS. 25(3):325-333, January 28th, 2011.

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy

Goodman, Derrick D; Zhou, Yun; Margot, Nicolas A; More

AIDS. 25(3):325-333, January 28th, 2011.

Author:
Mills, Edward
Author:
Moir, Susan

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Haïm-Boukobza, Stéphanie; Morand-Joubert, Laurence; Flandre, Philippe; More

AIDS. 25(3):341-344, January 28th, 2011.

Author:
Neaton, James D

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Soliman, Elsayed Z; Lundgren, Jens D; Roediger, Mollie P; More

AIDS. 25(3):367-377, January 28th, 2011.

Author:
Nelson, Mark

A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population

Nelson, Mark; Stellbrink, Hans-Jürgen; Podzamczer, Daniel; More

AIDS. 25(3):335-340, January 28th, 2011.

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Author:
Palella, Frank

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population

Nelson, Mark; Stellbrink, Hans-Jürgen; Podzamczer, Daniel; More

AIDS. 25(3):335-340, January 28th, 2011.

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children

Bunupuradah, Torsak; Kosalaraksa, Pope; Puthanakit, Thanyawee; More

AIDS. 25(3):315-323, January 28th, 2011.

Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals

Ho, Jason; Moir, Susan; Wang, Wei; More

AIDS. 25(3):295-302, January 28th, 2011.

Author:
Reiss, Peter

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Soliman, Elsayed Z; Lundgren, Jens D; Roediger, Mollie P; More

AIDS. 25(3):367-377, January 28th, 2011.

Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations

Soliman, Elsayed Z; Lundgren, Jens D; Roediger, Mollie P; More

AIDS. 25(3):367-377, January 28th, 2011.

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors

Salgado, Maria; Kirk, Gregory D; Cox, Andrea; More

AIDS. 25(3):385-387, January 28th, 2011.

1 2 Next